The James E.C. Walker, M.D. Professor of Medicine, University of Connecticut Health Center and the University of Connecticut School of Medicine
Infectious Disease
Dr. Paul R. Skolnik, MD
|
|
Give Review
Paul Skolnik is an expert in the field of Infectious Disease. He went to Perelman School of Medicine at the University of Pennsylvania. Doctor Paul R. Skolnik, MD is a published MD. He published 31 publications, including: 'Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes.' He is registered with Medicare.
Publications
- Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes.
- Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherence.
- A low-effort, clinic-wide intervention improves attendance for HIV primary care.
- A collaborative awareness system for chronic disease medication adherence applied to HIV infection.
- Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.
- Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy.
- A 24-year-old patient with Crohn's disease starting immunosuppressive therapy: vaccination issues to consider.
- Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
- A practical guide to vaccinating the inflammatory bowel disease patient.
- Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV.
- Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
- Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
- Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
- Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical center.
- Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells.
- The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV.
- Optimal recall period and response task for self-reported HIV medication adherence.
- Predictors of treatment for hepatitis C virus (HCV) infection in drug users.
- Adult and pediatric emergency department sexually transmitted disease and HIV screening: programmatic overview and outcomes.
- HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
- Approaching the CDC's guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testing.
- Evaluation of the Centers for Disease Control and Prevention's recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: who ...
- Tumor necrosis factor alpha leads to increased cell surface expression of CXCR4 in SK-N-MC cells.
- Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.
- Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts.
- Highly active antiretroviral therapy and viral response in HIV type 2 infection.
- Enfuvirtide, a new fusion inhibitor for therapy of human immunodeficiency virus infection.
- HIV therapy--what do we know, and when do we know it?
- Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, ch...
- Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.
Schools
Perelman School of Medicine University of Pennsylvania
Hospital Of The University Of Pennsylvania
Massachusetts General Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Massachusetts General Hospital -
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1679521710 | |
| NPPES Provider LastName | SKOLNIK | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 060303229 | |
| NPPES Provider State | CT | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 136.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679521710 |
| Last Name Of The Provider | SKOLNIK |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Lisa M. Chirch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tiara T. Hypolite, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geehan Suleyman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jurate Ivanaviciene, MD |
|
|
Dr. Justin D. Radolf, MD |
|
|
Dr. Omprakash B. Pillai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward L. Pesanti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kensley Nichols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Dorsky, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kevin O. Dieckhaus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen M. Crowe, MD |